• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估多发性硬化症患者身体活动与健康相关生活质量之间的关联。

Estimating the association between physical activity and health-related quality of life in individuals with multiple sclerosis.

机构信息

Partners MS Center, Brigham and Women's Hospital, 60 Fenwood Rd., Boston, MA 02115, United States; Department of Neurology, Harvard Medical School, Boston, MA, United States; Biostatistics Center, Massachusetts General Hospital, Boston, MA, United States.

Partners MS Center, Brigham and Women's Hospital, 60 Fenwood Rd., Boston, MA 02115, United States.

出版信息

Mult Scler Relat Disord. 2022 Sep;65:104006. doi: 10.1016/j.msard.2022.104006. Epub 2022 Jul 2.

DOI:10.1016/j.msard.2022.104006
PMID:35816952
Abstract

BACKGROUND

Higher levels of total physical activity (PA) are associated with better health-related quality of life (HRQOL) in individuals with multiple sclerosis (MS). The benefits of PA across the activity continuum have not been well-studied. The goal of this study was to compare the associations between total PA, strenuous PA, moderate PA, and mild PA and HRQOL in a large cohort of individuals with MS using both generic and neurologic disease-specific questionnaires. Longitudinal changes in PA and HRQOL over two years were also examined METHODS: Subjects enrolled in SysteMS completed the Godin Leisure Time Exercise Questionnaire (GLTEQ) to measure PA. Subjects also completed generic (SF-36) and neurologic disease-specific (NeuroQoL) HRQOL measures. GLTEQ and HRQOL measures were administered at baseline and 24 months. The associations between the GLTEQ total leisure activity (TLA), strenuous PA, moderate PA and mild PA and scores on NeuroQoL and SF-36 were estimated using Spearman's correlation coefficient and partial Spearman's correlation coefficient adjusting for age, sex and Expanded Disability Status Scale (EDSS) measured by a provider. To further investigate the associations between mild PA and HRQOL measures, the associations between mild PA and HRQOL were estimated in participants who reported no moderate or strenuous PA in the last week. The changes in GLTEQ TLA scores and each component score were compared to the changes in NeuroQoL and SF-36 over 24 months using Spearman's correlation coefficient and partial Spearman's correlation coefficient adjusting for age, sex and EDSS.

RESULTS

Statistically significant weak correlations were observed between GLTEQ TLA and NeuroQoL and SF-36 domains, with higher levels of TLA being associated with better HRQOL outcomes. After adjusting for age, sex and EDSS, all correlations were attenuated. Strenuous and moderate levels of PA were similarly associated with many HRQOL outcomes, but mild PA was only weakly correlated with NeuroQoL Lower Extremity Function. There was limited change in PA over 24 months. In a subgroup of participants who reported mild PA, but no moderate or strenuous PA, there were no significant associations with NeuroQoL or SF-36 domains at baseline, but increases in mild PA over two years were moderately associated with improvement on NeuroQoL Upper Extremity Function and SF-36 Mental Health and Mental Component Summary.

CONCLUSION

There were weak associations between TLA and HRQOL across a wide range of HRQOL variables. In addition, both strenuous PA and moderate PA were weakly associated with many HRQOL outcomes, but mild PA was only associated with lower extremity function. Increases in mild PA in a subgroup of individuals who reported no strenuous or moderate PA at baseline were associated with improvements in HRQOL at 24 months. These findings suggest that programs aimed at increasing PA across the activity continuum may lead to improvements in multiple areas of HRQOL in individuals with MS.

摘要

背景

多项研究表明,较高水平的总体身体活动(PA)与多发性硬化症(MS)患者的健康相关生活质量(HRQOL)呈正相关。但 across the activity continuum 的 PA 益处尚未得到很好的研究。本研究的目的是使用通用和神经疾病特异性问卷,比较 MS 患者大样本中总 PA、剧烈 PA、中度 PA 和轻度 PA 与 HRQOL 之间的关联。还检查了 2 年内 PA 和 HRQOL 的纵向变化。

方法

参加 SysteMS 的受试者完成了 Godin 休闲时间运动问卷(GLTEQ)来测量 PA。受试者还完成了通用(SF-36)和神经疾病特异性(NeuroQoL)HRQOL 测量。GLTEQ 和 HRQOL 测量在基线和 24 个月时进行。使用 Spearman 相关系数和偏 Spearman 相关系数估计 GLTEQ 总休闲活动(TLA)、剧烈 PA、中度 PA 和轻度 PA 与 NeuroQoL 和 SF-36 得分之间的关联,并根据年龄、性别和由提供者测量的扩展残疾状况量表(EDSS)进行调整。为了进一步研究轻度 PA 与 HRQOL 测量之间的关联,在报告过去一周没有中度或剧烈 PA 的参与者中,估计了轻度 PA 与 HRQOL 之间的关联。使用 Spearman 相关系数和偏 Spearman 相关系数比较 24 个月内 GLTEQ TLA 评分和每个分量评分与 NeuroQoL 和 SF-36 的变化,根据年龄、性别和 EDSS 进行调整。

结果

观察到 GLTEQ TLA 与 NeuroQoL 和 SF-36 域之间存在统计学上较弱的弱相关,TLA 水平较高与 HRQOL 结果较好相关。在调整年龄、性别和 EDSS 后,所有相关性均减弱。剧烈和中度 PA 水平与许多 HRQOL 结果相似相关,但轻度 PA 仅与 NeuroQoL 下肢功能弱相关。在 24 个月内,PA 变化有限。在报告轻度 PA 但无中度或剧烈 PA 的参与者亚组中,基线时与 NeuroQoL 或 SF-36 域无显著关联,但两年内轻度 PA 的增加与 NeuroQoL 上肢功能和 SF-36 心理健康和心理成分综合评分的改善中度相关。

结论

TLA 与广泛的 HRQOL 变量之间存在弱关联。此外,剧烈 PA 和中度 PA 均与许多 HRQOL 结果弱相关,但轻度 PA 仅与下肢功能相关。在基线时报告无剧烈或中度 PA 的个体亚组中,轻度 PA 的增加与 24 个月时的 HRQOL 改善相关。这些发现表明,旨在 across the activity continuum 增加 PA 的计划可能会导致 MS 患者的多个 HRQOL 领域得到改善。

相似文献

1
Estimating the association between physical activity and health-related quality of life in individuals with multiple sclerosis.评估多发性硬化症患者身体活动与健康相关生活质量之间的关联。
Mult Scler Relat Disord. 2022 Sep;65:104006. doi: 10.1016/j.msard.2022.104006. Epub 2022 Jul 2.
2
Comparison of patient-reported outcomes of physical activity and accelerometry in people with multiple sclerosis and ambulatory impairment: A cross-sectional study.多发性硬化症伴活动障碍患者身体活动和加速度计患者报告结局的比较:一项横断面研究。
Mult Scler Relat Disord. 2024 May;85:105532. doi: 10.1016/j.msard.2024.105532. Epub 2024 Mar 1.
3
Health-Related Quality of Life and Physical Activity in Older Adults With Multiple Sclerosis.患有多发性硬化症的老年人的健康相关生活质量与身体活动
Int J MS Care. 2023 Jan-Feb;25(1):26-29. doi: 10.7224/1537-2073.2021-136. Epub 2022 Aug 22.
4
Association between PROMIS10, SF-36 and NeuroQoL in persons with multiple sclerosis.多发性硬化症患者中 PROMIS10、SF-36 与 NeuroQoL 的相关性。
Mult Scler Relat Disord. 2023 Nov;79:105003. doi: 10.1016/j.msard.2023.105003. Epub 2023 Sep 15.
5
Erratum.勘误
Mult Scler. 2016 Oct;22(12):NP9-NP11. doi: 10.1177/1352458515585718. Epub 2015 Jun 3.
6
Work capacity and health-related quality of life among individuals with multiple sclerosis reduced by fatigue: a cross-sectional study.疲劳降低多发性硬化症患者的工作能力和健康相关生活质量:一项横断面研究。
BMC Public Health. 2013 Mar 15;13:224. doi: 10.1186/1471-2458-13-224.
7
Objective and subjective measures of daily physical activity in persons with Multiple Sclerosis beginning a rehabilitation regime: A cross-sectional study.对开始康复治疗的多发性硬化症患者日常身体活动的客观和主观测量:一项横断面研究。
Mult Scler Relat Disord. 2022 Dec;68:104394. doi: 10.1016/j.msard.2022.104394. Epub 2022 Nov 4.
8
Does the relationship between physical activity and quality of life differ based on generic versus disease-targeted instruments?基于通用型与疾病针对性工具,身体活动与生活质量之间的关系是否存在差异?
Ann Behav Med. 2008 Aug;36(1):93-9. doi: 10.1007/s12160-008-9049-4. Epub 2008 Aug 22.
9
Assessing physical activity and health-related quality of life in individuals with spinal cord injury: a national survey in Thailand.评估脊髓损伤个体的身体活动和与健康相关的生活质量:泰国的全国性调查。
Disabil Rehabil. 2022 Nov;44(23):7048-7058. doi: 10.1080/09638288.2021.1979665. Epub 2021 Sep 30.
10
Association of leisure and occupational physical activities and health-related quality of life: Tehran Lipid and Gluycose Study.休闲和职业体力活动与健康相关生活质量的关系:德黑兰血脂和血糖研究。
Health Qual Life Outcomes. 2020 Jan 20;18(1):13. doi: 10.1186/s12955-020-1272-0.

引用本文的文献

1
Effectiveness of Ocrelizumab on Disease Progression and Disability Status in Multiple Sclerosis Patients: A Two-Year Prospective Cohort Study.奥瑞珠单抗对多发性硬化症患者疾病进展和残疾状态的疗效:一项为期两年的前瞻性队列研究。
J Clin Med. 2025 Jan 16;14(2):553. doi: 10.3390/jcm14020553.
2
Be Cool: A Holistic and Innovative Approach to Rehabilitation in Multiple Sclerosis: Study Protocol for a Randomized Controlled Trial.保持冷静:一种针对多发性硬化症康复的全面创新方法:一项随机对照试验的研究方案
Healthcare (Basel). 2024 Apr 23;12(9):870. doi: 10.3390/healthcare12090870.